PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA
Clinical trials for PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a DNA-Repair blocker boost chemo in tough lung cancer?
Disease control OngoingThis study tests whether adding the experimental drug berzosertib to standard chemotherapy (topotecan) helps people with small cell lung cancer that has returned after initial treatment. About 104 participants will receive either the combo or topotecan alone. The goal is to see i…
Matched conditions: PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Triple-Drug attack aims to shrink returned lung cancer
Disease control OngoingThis early-phase trial tests a three-drug combination for small cell lung cancer that has come back after treatment. The drugs include a targeted therapy (tazemetostat), a chemotherapy (topotecan), and an immunotherapy (pembrolizumab). The goal is to find the safest dose and see …
Matched conditions: PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New drug combo shows promise for tough lung cancer
Disease control OngoingThis study tests whether combining durvalumab (an immunotherapy) with lurbinectedin (a chemotherapy drug) can help control advanced small cell lung cancer that has come back after prior treatment. About 29 adults whose cancer returned or didn't respond to standard chemo and immun…
Matched conditions: PLATINUM-SENSITIVE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:01 UTC